Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study

References

• Abdelbary G, Fahmy RH. (2009). Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech 10:211–9.
   PubMed Web of Science ®Google Scholar
• Abdel-Mottaleb MM, Mortada ND, El-Shamy AA, Awad GA. (2009). Physically cross-linked polyvinyl alcohol for the topical delivery of Fluconazole. Drug Dev Ind Pharm 35:311–20.
   PubMed Web of Science ®Google Scholar
• Agalakshmi S, Ramaswamy SR, Shanmuganathan S. (2014). Formulation and evaluation of stimuli sensitive pH triggered in-situ gelling system of Fluconazole in ocular drug delivery. Int J Pharm Sci Res 5:1339–44.
   Google Scholar
• Agrawal Y, Petkar KC, Sawant KK. (2010). Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. Int J Pharm 401:93–102.
   PubMed Web of Science ®Google Scholar
• Ahlin P, Kristl J, Smid-Kobar J. (1998). Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta Pharm 48:257–67.
   Google Scholar
• Ahmed IS, El Hosayb R, Shalabyb S, Noura S. (2014). Preparation and in-vitro evaluation of poly-caprolactone nanoparticles containing atorvastatin calcium. J Pharm Res Opin 4:8–18.
   Google Scholar
• Alekha KD, William FE. (2006). Fluconazole. In: Florey K. (ed.) Analytical profiles of drug substances and excipients. London, UK: Academic Press, 57–113.
   Google Scholar
• Ammar HO, Ghorab M, Mohmoud AA, et al. (2011). Preparation and evaluation of hydrogels as a vehicle for topical delivery of lornoxicam. Int J Drug Formulat Res 2:254–74.
   Google Scholar
• Bahari LAS, Hamishehkar H. (2016). The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers, a comparative literature review. Adv Pharm Bull 6:143–51.
   PubMed Web of Science ®Google Scholar
• Banerjee M, Ghosh AK, Basak S, et al. (2012). Comparative evaluation of efficacy and safety of topical fluconazole and clotrimazole in the treatment of tinea corporis. J Pak Assoc Dermatol 22:342–9.
   Google Scholar
• Barnes HA. (1997). Thixotropy – a review. J Non-Newton Fluid Mech 70:1–33.
   Web of Science ®Google Scholar
• Bernfild M, Gotte M, Park PW, et al. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729–77.
   PubMed Web of Science ®Google Scholar
• Bidkar S, Jain D, Padsalg A, et al. (2007). Formulation development and evaluation of Fluconazole gel in various polymer bases. Asian J Pharm 1:63–8.
   Google Scholar
• Carlfors J, Edsman K, Petersson R, Jörnving K. (1998). Rheological evaluation of gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 6:113–9.
   PubMed Web of Science ®Google Scholar
• Castelli F. (2005). Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm 8:304–231.
   Google Scholar
• Cavalli R, Caputo O, Gasco MR. (1993). Solid lipospheres of doxorubicin and idarubicin. Int J Pharm 89:R9–R12.
   Web of Science ®Google Scholar
• Crespo-Erchiga V, Florencio VD. (2006). Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 19:139–47.
   PubMed Web of Science ®Google Scholar
• Durán-Lobato M, et al. (2013). Statistical analysis of solid lipid nanoparticles produced by high-pressure homogenization: a practical prediction approach. J Nanopart Res 15:1–14.
   Web of Science ®Google Scholar
• Dutta S, Bajaj AK, Basu S, Dikshit A. (2002). Pityriasis versicolor: socioeconomic and clinico-mycologic study in India. Int J Dermatol 41:823–4.
   PubMed Web of Science ®Google Scholar
• Elnaggar YS, Etman SM, Abdelmonsif DA, Abdallah OY. (2015). Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies. Int J Nanomedicine 10:5459–73.
   PubMed Web of Science ®Google Scholar
• Ekambaram P, Sathali AA. (2011). Formulation and evaluation of solid lipid nanoparticles of ramipril. J Young Pharm 3:216–20.
   PubMedGoogle Scholar
• El-Badry M, Hassan MA, Ibrahim MA, Elsaghir H. (2013). Performance of poloxamer 407 as hydrophilic carrier on the binary mixtures with nimesulide. Farmacia 61:1137–50.
   Web of Science ®Google Scholar
• Faergemann J. (1995). Tinea versicolor (Pityriasis versicolor). In: Demis DJ, editor. Clinical dermatology. Philadelphia (PA): Lippincott-Raven, 1–9.
   Google Scholar
• Faergemann J. (1999). Pityrosporum species as a cause of allergy and infection. Allergy 54:413–9.
   PubMed Web of Science ®Google Scholar
• Farschian M, Yaghoobi R, Samadi K. (2002). Fluconazole versus ketoconazole in the treatment of tinea versicolor. J Dermatol Treat 13:73–6.
   PubMed Web of Science ®Google Scholar
• Framil VM, Melhem MS, Szeszs MW, Zaitz C. (2011). New aspects in the clinical course of pityriasis versicolor. An Bras Dermatol 86:1135–40.
   PubMed Web of Science ®Google Scholar
• Gokce EH, Sandri G, Bonferoni MC, et al. (2008). Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm 364:76–86.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Bluhm R, Summerbell R. (2002). Pityriasis versicolor. J Eur Acad Dermatol Venereol 16:19–33.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Daigle D, Foley KA. (2015). Drug safety assessment of oral formulations of ketoconazole. Expert Opin Drug Saf 14:325–34.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Kogan N, Batra R. (2005). Pityriasis versicolor: a review of pharmacological treatment options. Expert Opin Pharmacother 6:165–78.
   PubMed Web of Science ®Google Scholar
• Gupta M, Goyal AK, Paliwal SR, et al. (2010). Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res 20:341–50.
   PubMed Web of Science ®Google Scholar
• Gupta M, Vyas SP. (2012). Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids 4:454–61.
   Web of Science ®Google Scholar
• Hackett MJ, Zaro JL, Shen W, et al. (2013). Fatty acids as therapeutic auxiliaries for oral and parenteral formulations. Int J Nanomedicine 8:2733–44.
   PubMed Web of Science ®Google Scholar
• Hald M, Arendrup MC, Svejgaard EL, et al. (2015). Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases. Acta Derm Venerol 95:12–9.
   PubMed Web of Science ®Google Scholar
• Haneke E. (1990). Fluconazole levels in human epidermis and blister fluid (letter). Br J Dermatol 12:318–26.
   Google Scholar
• Illing A, Unruh T. (2004). Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles. Int J Pharm 284:123–31.
   PubMed Web of Science ®Google Scholar
• Jawahar N, Eaggapanath T, Nagaswamy V, Samantha JS. (2009). Preparation and characterization of PLGA – nanoparticles containing a hypertensive agent. Int J Pharm Tech Res 2:390–3.
   Google Scholar
• Jenning V, Thunemann AF, Gohla SH. (2000). Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199:167–77.
   PubMed Web of Science ®Google Scholar
• Jessica E, Zlatko K, Allison J. (2013). Nanotechnological advances in cutaneous medicine. J Nanomater 2013:808234, 8 pages.
   Web of Science ®Google Scholar
• Kamboj S, Bala S, Nair AB. (2010). Solid lipid nanoparticles: an effective lipid based technology for poorly water soluble drugs. Int J Pharm Sci Rev Res 5:78–90.
   Google Scholar
• Karakas M, Durdu M, Hamdi R. (2005). Oral fluconazole in the treatment of tinea versicolor. J Dermatol 32:19–21.
   PubMed Web of Science ®Google Scholar
• Kaur LP, Guleri TK. (2013). Topical gel: a recent approach for novel drug delivery. J Drug Deliv Ther 3:1–5.
   Google Scholar
• Kesharwani R, Sachan A, Singh S, Patel D. (2016). Formulation and evaluation of solid lipid nanoparticle (SLN) based topical gel of etoricoxib. J Appl Pharm Sci 6:124–31.
   Google Scholar
• Khalil RM, Abd-Elbary A, Kassem MA, et al. (2013). Formulation and characterization of nystatin-loaded nanostructured lipid carriers for topical delivery against cutaneous candidiasis. Br J Pharm Res 4:490–512.
   Google Scholar
• Khalil RM, Abd-Elbary A, Kassem MA, et al. (2014). Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam. Pharm Dev Technol 19:304–14.
   PubMed Web of Science ®Google Scholar
• Koltin Y, Hitchcock CA. (1997). Progress in the search for new triazole antifungal agents. Curr Opin Chem Biol 1:176–82.
   PubMed Web of Science ®Google Scholar
• Koneman EW. (2006). Color atlas and text book of diagnostic microbiology, vol. 6. Philadelphia (PA): Lippincott Williams and Wilkins, 1187.
   Google Scholar
• Kumar SR, Himmestein KJ. (1995). Modification of in situ gelling behavior of carbopol solutions by hydroxyl propyl methyl cellulose. J Pharm Sci 84:344–8.
   PubMed Web of Science ®Google Scholar
• Kurade SM, Amladi SA, Miskeen AK. (2006). Skin scraping and a potassium hydroxide mount. IJDVL J 72:238–41.
   Google Scholar
• Lee CM, Maibach HI. (2006). DEEp percutaneous penetration into muscles and joints. J Pharm Sci 95:1405–12.
   PubMed Web of Science ®Google Scholar
• Lippacher A, Muller RH, Madder K. (2002). Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. Eur J Pharm Biopharm 53:155–60.
   PubMed Web of Science ®Google Scholar
• Liu W, Hu M, Liu W, et al. (2008). Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm 364:135–41.
   PubMed Web of Science ®Google Scholar
• Mahato RI. (2007). Pharmaceutical dosage forms and drug delivery. Boca Raton: CRC Press.
   Google Scholar
• Manjunath K, Ready JS, Venkateswarlu V. (2005). Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol 27:127–44.
   PubMed Web of Science ®Google Scholar
• Mathy FX, Ntivunwa D, Verbeeck RK, Pre’at V. (2005). Fluconazole distribution in rat dermis following intravenous and topical application: a microdialysis study. J Pharm Sci 94:770–80.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Meader K. (2012). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 64:83–101.
   Web of Science ®Google Scholar
• Mellen LA, Vallee J, Feldman SR, Fleischer AB. (2004). Treatment of pityriasis versicolor in the United States. J Dermatol Treat 15:189–92.
   PubMedGoogle Scholar
• Morais PM, Cunha MG, Frota MZ. (2010). Clinical aspects of patients with pityriasis versicolor seen at a referral center for tropical dermatology in Manaus, Amazonas, Brazil. An Bras Dermatol 85:797–803.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ray S, Thakur RS. (2009). Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 71:349–58.
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50:161–77.
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. (2002). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–S55.
   PubMed Web of Science ®Google Scholar
• Müller RH, Runge SA, Ravelli V, et al. (2008). Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm 68:535–44.
   PubMed Web of Science ®Google Scholar
• Müller-Goymann CC. (2004). Physiochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 58:343–56.
   PubMed Web of Science ®Google Scholar
• Naidu NB, Chowdary KPR, Murthy KVR, et al. (2004). Physicochemical characterization and dissolution properties of meloxicam cyclodextrin binary systems. J Pharm Bio Med Anal 35:75–86.
   PubMed Web of Science ®Google Scholar
• Nanjawade BK, Manjappa AS, Murthy RS, Pol YD. (2009). A novel pH triggered in situ gel for sustained ophthalmic delivery of ketorlac tromithamine. Asian J Pharm Sci 4:189–99.
   Google Scholar
• Nayak AP, Patankar TS, Madhusudhan B, Souto EB. (2010). Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B 81:263–73.
   PubMed Web of Science ®Google Scholar
• Negi JS, Chattopadhyay P, Sharma AK, Ram V. (2013). Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique. Eur J Pharm Sci 48:231–9.
   PubMed Web of Science ®Google Scholar
• Nicky L, Conrad M, Kabanda T, et al. (2008). Dose response effect of high‐dose fluconazole for HIV‐associated cryptococcal meningitis in Southwestern Uganda. Clin Infect Dis 47:1556–61.
   PubMed Web of Science ®Google Scholar
• Paliwal R, Rai S, Vaidya B, et al. (2009). Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine Nanotechnol Biol Med 5:184–91.
   PubMed Web of Science ®Google Scholar
• Pandita D, Ahuja A, Velpandian T, et al. (2009). Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Pharmazie 64:301–10.
   PubMed Web of Science ®Google Scholar
• Pandurangan DK, Bodagala P, Palanirajan VK, Govindaraj S. (2016). Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel. Int J Pharm Investig 6:56–62.
   PubMed Web of Science ®Google Scholar
• Paolicelli P, Cerreto F, Cesa S, et al. (2009). Influence of the formulation components on the properties of the system SLN-dextran hydrogel for the modified release of drugs. J Microencapsul 26:355–64.
   PubMed Web of Science ®Google Scholar
• Patel AN, Prajapati BG. (2016). Design and development of solid lipid nanoparticles (SLNs) of zolmitriptan for the treatment of migraine. Eur J Biomed Pharm Sci 3:253–9.
   Google Scholar
• Pople PV, Singh K. (2006). Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech 7:E63–9.
   PubMed Web of Science ®Google Scholar
• Prasad RS, Yandrapu SK, Manavalan R. (2010). Preparation and characterization of Itraconazole solid dispersion for improved oral bioavailability. Int J ChemTech Res 2:133–42.
   Google Scholar
• Priyanka K, Sathali AH. (2012). Preparation and evaluation of Montelukast sodium loaded solid lipid nanoparticles. J Young Pharm 4:129–37.
   PubMedGoogle Scholar
• Radtke M, Souto BE, Muller RH. (2005). Nanostructured lipid carriers: a novel generation of solid lipid drug carriers. Pharm Tech Europe 17:45–50.
   Google Scholar
• Ramasamy T, Kandasamy US, Ruttala H, Shanmugam S. (2012). Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent. Macromol Res 20:682–92.
   Web of Science ®Google Scholar
• Ruhnke M, Hartwig K, Kofla G. (2008). New options for treatment of candidaemia in critically ill patients. Clin Microbiol Infect 4:46–54.
   Web of Science ®Google Scholar
• Shah M, Agrawal YK, Garala K, Ramkishan A. (2012). Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride. Indian J Pharm Sci 74:434–42.
   PubMed Web of Science ®Google Scholar
• Shahid J, Ihsan Z, Khan S. (2000). Oral fluconazole in the treatment of pityriasis versicolor. J Dermatol Treat 1:101–3.
   Web of Science ®Google Scholar
• Sheth B. (2007). Viscosity measurement and interpretation of viscosity data. J Text Stud 7:157–78.
   Google Scholar
• Song JC, Deresinski S. (2005). Hepatotoxicity of antifungal agents. Curr Opin Investig Drugs 6:170–7.
   PubMedGoogle Scholar
• Srividya B, Cardoza RM, Amin PD. (2001). Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 73:205–11.
   PubMed Web of Science ®Google Scholar
• Thatipamula RP, Palem CR, Gannu R, et al. (2011). Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. DARU 19:23–32.
   PubMed Web of Science ®Google Scholar
• Thirumurthy M, Sethuraman G, Srinivas CR. (2002). KOH mount for superficial fungal infections using cellophane tape: Comparison with standard technique. Indian J Dermatol Venereol Leprol 68:136.
   PubMedGoogle Scholar
• Tiyaboonchai W, Tungpradit W, Plianbangchang P. (2007). Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 337:299–306.
   PubMed Web of Science ®Google Scholar
• Vivek K, Reddy H, Murthy RSR. (2007). Investigations of the effect of the lipid matrix on drug entrapment, in vitro release and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 8:E1–9.
   PubMed Web of Science ®Google Scholar
• Wamorkar V, Varma MM, Manjunath SY. (2011). Formulation and evaluation of stomach specific in-situ gel of metoclopramide using natural, bio-degradable polymers. Int J Res Pharm Biomed Sci 2:193–201.
   Google Scholar
• Watkinson A, Bunge A, Hadgraft, Lane M. (2013). Nanoparticles do not penetrate human skin-a theoretical perspective. Pharm Res 30:1943–6.
   PubMed Web of Science ®Google Scholar
• Wei L, Yang Y, Shi K, et al. (2016). Preparation and characterization of loperamide-loaded dynasan 114 solid lipid nanoparticles for increased oral absorption in the treatment of diarrhea. Front Pharmacol 7:332.
   PubMed Web of Science ®Google Scholar
• Westesen K, Bunjes H, Koch MHJ. (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48:223–36.
   Web of Science ®Google Scholar
• Wissing SA, Müller RH. (2002). The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm 242:377–9.
   PubMed Web of Science ®Google Scholar
• Yan JY, Nie XL, Tao QM, et al. (2015). Ketoconazole associated hepatotoxicity: a systematic review and meta- analysis. Biomed Sci Rep 26:605–610.
   Google Scholar
• Yazdanpanah MJ, Azizi H, Suizi B. (2007). Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. Mycoses 50:311–313.
   PubMed Web of Science ®Google Scholar